Amorfix and BioMosaics collaborate to develop a blood test for liver cancer
27-Apr-2009 -
Amorfix Life Sciences Ltd. and BioMosaics Inc. announced a collaboration to develop and commercialize a blood-based assay for early detection of hepatocellular carcinoma (HCC) or primary liver cancer. This effort is possible due to an "Intellectual Property Development and Commercialization ...
antibodies
biomarker
blood tests
+5